NIH-funded research U01 cooperative agreement

Mapping the early stages of skin cancer development

Official title: Pre-cancer atlas of skin cancer

Funded at University of California, San Francisco · NIH-10995082 · Data updated 2026-11-12

This study is looking at how skin cancer, especially melanoma and squamous cell carcinoma, develops over time by examining skin samples to see how skin cells change and how the immune system interacts with these changes before cancer starts, helping us understand the journey from early signs to full-blown cancer.

More Skin Cancer research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco
NIH-funded
Lab location1 site (San Francisco, United States)
Project startSeptember 1, 2024
Project endAugust 31, 2029
Funding year2024
Award (this year)$1,019,013
NIH project number1U01CA294536-01
Project IDNIH-10995082 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with a history of skin lesions or those at high risk for developing skin cancer.

Less likely to help

Patients who do not have any skin lesions or are not at risk for skin cancer may not benefit from this research.

What this research studies

This research aims to create a detailed atlas that tracks the early development of skin cancer, particularly focusing on melanoma and cutaneous squamous cell carcinoma. By utilizing skin samples, which are easily accessible, the study will analyze how skin cells accumulate mutations over time and how these changes relate to cancer progression. The research will also explore the role of the immune system in this process, particularly how it interacts with tumors before they become cancerous. Through various molecular assays, the project seeks to understand the transition from pre-cancerous lesions to full-blown cancer.

Why it matters

Potential benefit: If successful, this research could lead to improved early detection and prevention strategies for skin cancer.

How similar studies have gone: Previous research has shown promising results in understanding tumor evolution and immune interactions in other cancer types, suggesting potential success for this novel approach.

Where this research is happening

  • University of California, San Francisco
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Shain, Alan Hunter — University of California, San Francisco
  • Study coordinator: Shain, Alan Hunter

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.